Holen Sie sich die Stockscreener-App
2.62
4.80%
0.12
Handel nachbörslich:
2.67
0.05
+1.91%
Schlusskurs vom Vortag:
$2.50
Offen:
$2.54
24-Stunden-Volumen:
8.61M
Relative Volume:
0.96
Marktkapitalisierung:
$1.09B
Einnahmen:
$1.70B
Nettoeinkommen (Verlust:
$-123.70M
KGV:
-9.8385
EPS:
-0.2663
Netto-Cashflow:
$-178.21M
1W Leistung:
+15.93%
1M Leistung:
-10.27%
6M Leistung:
-42.29%
1J Leistung:
+31.00%
1-Tages-Spanne:
$2.505
$2.67
1-Wochen-Bereich:
$2.12
$2.67
52-Wochen-Spanne:
$2.105
$4.87
Clover Health Investments Corp Stock (CLOV) Company Profile
Firmenname
Clover Health Investments Corp
Sektor
Branche
Telefon
(201) 432-2133
Adresse
30 MONTGOMERY STREET, JERSEY CITY
Vergleichen Sie CLOV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
2.62 | 1.28B | 1.70B | -123.70M | -178.21M | -0.2663 |
|
UNH
Unitedhealth Group Inc
|
271.81 | 236.90B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
65.90 | 83.09B | 386.46B | 4.49B | 4.78B | 3.58 |
|
CI
Cigna Group
|
287.10 | 74.87B | 261.22B | 5.40B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
294.43 | 65.86B | 189.25B | 5.35B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
281.99 | 33.07B | 117.76B | 1.21B | 2.39B | 9.95 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Eingeleitet | Craig Hallum | Buy |
| 2024-10-07 | Eingeleitet | UBS | Neutral |
| 2022-02-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-02-02 | Hochstufung | Cowen | Underperform → Market Perform |
| 2022-01-19 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-01-10 | Fortgesetzt | Citigroup | Neutral |
| 2022-01-07 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Underperform |
| 2021-09-02 | Fortgesetzt | Citigroup | Neutral |
| 2021-07-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-06-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-05-17 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-02-02 | Eingeleitet | Citigroup | Buy |
| 2021-02-01 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Clover Health Investments Corp Aktie (CLOV) Neueste Nachrichten
Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know - ca.finance.yahoo.com
Clover Health rises after former CEO buys shares - MSN
Healthcare AI Market Explodes 38.5% Annually as Diagnostics Gain FDA Traction - The Globe and Mail
Clover Health at Canaccord Conference: Strategic Tech-Driven Growth - Investing.com
Clover Health Engages Shareholders with FAQ Release - TipRanks
Insider Buying at Clover Health: A Signal of Value or Short-Term Confidence? - AInvest
Clover Health rises after former CEO buys shares (CLOV) - Seeking Alpha
Clover Health: Short-Term Pain Hides Its Long-Term Profitability Potential (NASDAQ:CLOV) - Seeking Alpha
Clover Health Stock (CLOV): Insider Confidence Sparks Rally - Value The Markets
Co-Founder & Executive Chairman of Clover Health Investments Vivek Garipalli Buys 32% More Shares - simplywall.st
Clover drops despite Q2 beat amid concerns over medical cost trends - MSN
CLOVER HEALTH INVESTMENTS, CORP. /DE SEC 10-Q Report - TradingView
Clover Health Earnings Call: Growth and Profitability Insights - The Globe and Mail
Clover Health Investments, Corp. (NASDAQ:CLOV) Q2 2025 Earnings Call Transcript - Insider Monkey
Clover Health Investments Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Clover Health shares rise 1.33% premarket after 2Q25 earnings call and UBS price target adjustment. - AInvest
Clover Health CEO Reynoso sells $19,718 in shares By Investing.com - Investing.com Canada
Clover Health CEO Reynoso sells $19,718 in shares - Investing.com India
Clover Health Investments, Corp. (CLOV) Q2 Earnings Meet Estimates - MSN
Clover Health stock drops on Q2 report release - Nashville Post
Clover stock drops despite Q2 beat (CLOV:NASDAQ) - Seeking Alpha
CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View - TradingView
UBS Adjusts Price Target on Clover Health Investments to $3 From $4.50, Maintains Neutral Rating - MarketScreener
Community Health Systems, Inc. shares fall 1.61% premarket after Clover Health reports Q2 loss. - AInvest
Clover Health shares fall 11.58% premarket after reporting a Q2 loss of $10.58 million. - AInvest
Clover Health Investments Corp (CLOV) Q2 2025 Earnings Call Highlights: Surpassing Growth ... - Yahoo Finance
Clover Health Investments Corp (CLOV) Q2 2025 Earnings Call High - GuruFocus
Clover Health Reports Strong Q2 2025 Growth - TipRanks
Clover Health (CLOV) Q2 Sales Up 34% - AOL.com
Clover Health Investments Q2 2025 Earnings Call Transcript - AInvest
Clover Health Investments earnings beat by $0.05, revenue topped estimates By Investing.com - Investing.com South Africa
Clover Health Posts Rising Revenue And Beats Profit Targets - Finimize
Earnings call transcript: Clover Health Q2 2025 sees revenue beat, stock dips - Investing.com
Clover Beats Q2 Estimates, Stock Drops: Here Are The Details - 富途牛牛
Clover Health (NASDAQ:CLOV) Beats Q2 Sales Targets But Stock Drops - Yahoo Finance
Clover Health Investments Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Clover Health Q2 revenue beats expectations - MarketScreener
Clover Health Q2 2025 slides: 32% membership growth amid sustained profitability - Investing.com Nigeria
Earnings Flash (CLOV) Clover Health Investments, Corp. Reports Q2 Revenue $477.6M, vs. FactSet Est of $468.3M - MarketScreener
Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth - The Manila Times
RENEW 8-K: Ninth SPAC Extension Adds $250k to Trust, Deadline Sep 5 2025 | CLOV SEC FilingForm 8-K - Stock Titan
Clover Health Investments, Corp. shares rise 1.74% premarket after small business sales tick up in July. - AInvest
Counterpart Health Releases Whitepaper Linking AI-Powered Assistant to Improved COPD Management and Reduced Hospitalizations - Quiver Quantitative
Groundbreaking Study: AI Assistant Cuts COPD Hospital Readmissions by 18%, Transforms Patient Care - Stock Titan
What To Expect From Clover Health Investments Corp (CLOV) Q2 2025 Earnings - Yahoo Finance
Is Clover Health Investments Corp. stock reversal real or fakeDaily Stock Forecast Powered by AI Tools - Newser
Finanzdaten der Clover Health Investments Corp-Aktie (CLOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.88%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):